articleTop 1% cited
Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort
AIDS · 2005 · Vol. 19(6) · pp. 593–601
Déborah Konopnicki✉(Centre Hospitalier Universitaire de Saint-Pierre)Amanda Mocroft(University College London)Stéphane De Wit(Centre Hospitalier Universitaire de Saint-Pierre)Francisco Antunes(Hospital de Santa Maria)Bruno Ledergerber(University Hospital of Zurich)Christine Katlama(Sorbonne Université)Kai Zilmer(East Tallinn Central Hospital)Stefano Vella(Istituto Superiore di Sanità)Ole Kirk(Hvidovre Hospital)Jens Lundgren(Centre Hospitalier Universitaire de Saint-Pierre)
Abstract
The prevalence of HBV coinfection was 9% in the EuroSIDA cohort. Chronic HBV infection significantly increased liver-related mortality in HIV-1-infected patients but did not impact on progression to AIDS or on viral and immunological responses to HAART.
Hepatitis B Virus StudiesHepatitis C virus researchHIV/AIDS Research and InterventionsCoinfectionMedicineHBsAgInternal medicineCohortIncidence (geometry)Hepatitis BMortality rateCohort studyHepatitis C
MeSH terms
AdultCause of DeathEuropeHepatitis B Surface AntigensHumansMaleCohort StudiesHIV-1HIV InfectionsPrevalenceDisease ProgressionHepatitis B, ChronicAntiretroviral Therapy, Highly Active
Citations
563
FWCI
23.87
field-weighted impact
References
27
Percentile
100%
vs. same field & year
Citations per year
Cited by
Liver-Related Deaths in Persons Infected With the Human Immunodeficiency Virus
Archives of Internal Medicine · 2006 · 1,107 citations
Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy
AIDS · 2014 · 589 citations
Epidemiology of viral hepatitis and HIV co-infection
Journal of Hepatology · 2005 · 1,011 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.